Aesthetics Combination Therapy Market – Insights
Cosmetic plastic surgery is commonly used to restore youthful appearance. It includes both surgical and nonsurgical procedures. Botulinum toxin and fillers are a widely used combination. Intense pulsed light (IPL) plus botulinum toxin is an effective combination for muscle response, lentigines, pore size and facial texture.
The global aesthetics combination therapy market is estimated to account for US$ 4,698 Mn in terms of value by the end of 2027.
Global Aesthetics Combination Therapy Market: Drivers
High effectiveness of combination therapy over individual procedures is expected to propel growth of the global aesthetics combination therapy market over the forecast period. For instance, use of fillers with tissue tightening can be effective against aging face. The aging face is a combined result of laxity and loss of volume. Although tissue tightening can offer firmness to the skin, the process fails to correct the loss of volume in the perioral region. This can be done by adding fillers.
Moreover, increasing disposable income is also expected to aid in growth of the market. For instance, according to the National Bureau of Statistics (China), the urban and rural per capita disposable income in China reached US$ 5,600 and US$ 2,000 in 2018, an increase of 5.6% and 6.6% in real terms after deducting price factors, respectively.
North America region held dominant position in the global aesthetics combination therapy market in 2019, accounting for 38.4% share in terms of value, followed by 2027.
Figure 1. Global Aesthetics Combination Therapy Market Share (%), by Region, 2019
Source: Coherent Market Insights Analysis (2020)
Global Aesthetics Combination Therapy Market: Restraints
Lack of clinical evidences for treatments other than botulinum is expected to hinder growth of the market. There is significant dearth of documented clinical evidence and efficacies for treatments other than botulinum, which deters customers, especially affluent ones with higher spending power, from using treatments other than botulinum.
Moreover, early product introduction is expected to increase incidence of adverse drug reactions, thereby limiting growth of the market. Market players face strong competition to introduce newer products in the market, which could also lead to early introduction of products such as peels and topical solutions. However, this may lead to adverse drug reactions such as skin rashes, pain, and hyper-pigmentation.
Global Aesthetics Combination Therapy Market: Opportunities
Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global aesthetics combination therapy market over the forecast period. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.
Moreover, conducting clinical trials to validate aesthetics combination therapies is also expected to aid in growth of the market. Reliance on anecdote rather than scientific clinical trials to create and refine treatment protocols is a major drawback in combination procedures. Clinical trials are therefore required for certain combinations that are perceived as more established in order to validate their usage together.
BTx-A/Laser segment in the global aesthetics combination therapy market was valued at US$ 531.6 Mn in 2019 and is expected to reach US$ 887.5 Mn by 2027 at a CAGR of 6.6% during the forecast period.
Market Trends/Key Takeaways
Combination therapies are set to witness high potential in Europe. Faltering out-of-pocket expenses for a service considered a “desire” or luxury coupled with tricky pricing of combination treatments involving a device and a drug are factors successfully helping in generating revenues in the market. The trend in very prominent in countries such as the U.K., Russia, and Spain.
Moreover, lower melanin and collagen content in people of European descent and deep sun exposures due to rapid depletion of the ozone layer are also expected to boost demand for combination therapies in Europe.
Global Aesthetics Combination Therapy Market: Competitive Landscape
Major players operating in the global aesthetics combination therapy market include, Alma Lasers, Lumenis Ltd., Cynosure Inc., Bausch Health Companies Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA, Cutera, Inc., Syneron Medical Ltd., and Allergan.
Aesthetics Combination Therapy Market: Key Developments
Major players in the market are focused on launching new products to expand their produxt portfolio. For instance, in May 2019, Alma Lasers launched Profhilo, an advanced hyaluronic acid product for aesthetic practices, in Hong Kong.
Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in June 2019, AbbVie Inc. agreed to acquire Allergan PLC for about US$ 63 billion.